Thus, our data support a model in which age-associated CD44 expression in hepatocytes contributes to a HCC-prone niche by fostering an IL6/JAK/STAT3-dependent immune suppressive microenvironment. This evidence concerns the gene STAT3 and hepatocellular carcinoma.